2025 Schedule and Abstracts
9:30am Sponsored Light Breakfast & Registration
9:50am Opening Statements (Dr. Karla Kaun)
10:00am 10X Genomics
Explore the brain’s circuitry at the cellular level
The quest to decipher the fundamental biology driving complicated, multifactorial neurodegenerative, psychiatric, and neurodevelopmental diseases requires approaches that build a holistic understanding, starting from single cells to tissues and beyond. Uncover the cellular contributions of individual cell types and subtypes to neurological development and addiction by building high resolution molecular profiles using Chromium Single Cell products from 10x Genomics. Explore additional layers of disease complexity by surveying the regulatory landscape of disease-associated cells with Chromium Single Cell ATAC, or unify your view of the transcriptome and epigenome by simultaneously profiling open chromatin regions and gene expression in these cells with Chromium Single Cell Multiome ATAC + Gene Expression. Gain a more comprehensive understanding of spatiotemporal transcriptome changes and protein expression patterns driving pathogenesis and disease progression in tissue slices, while maintaining the morphological integrity of your samples, with Visium Spatial and Xenium In Situ products. Journey deeper into the brain with 10x single cell and spatial technologies to see neurobiology in new ways, as referenced in more than 1,300 Neuroscience publications.
10:05am Invited Talks 1:
Camron Bryant, PhD
Professor
Pharmaceutical Sciences
Northeastern University
Emerging role of Zinc fingers and homeoboxes 2 (Zhx2) in sex-specific brain oxycodone metabolite (oxymorphone) levels and oxycodone addiction model behaviors
Oxymorphone (OMOR) is a potent and efficacious metabolite of oxycodone (OXY, active ingredient of OxyContin®), with an emerging role in acute OXY analgesia and reward. However, the contribution of OMOR to OXY withdrawal is less explored. We recently genetically mapped and validated Zinc fingers and homeoboxes 2 (Zhx2) as a quantitative trait gene underlying female-specific increases in brain OMOR associated with increased OXY locomotion and reward. Here, I will present new results extending Zhx2’s effects in modulating spontaneous and naloxone-precipitated withdrawal traits following high-dose OXY using video image analysis and conditioned place aversion procedures and potential mechanisms.
Philipp Mews, PhD
Assistant Professor
Pharmacology, Physiology & Biophysics
Boston University
Metabolic‑Epigenetic Coupling Drives Cocaine-Induced Gene Programs
Cocaine use disorder involves persistent transcriptional reprogramming in reward circuitry. While these shifts are traditionally attributed to transcription factors and chromatin remodelers, emerging evidence highlights a critical role for metabolism: chromatin‑associated enzymes generate cofactors like S‑adenosyl‑methionine (SAM), the universal methyl donor for histone methylation. We find that cocaine enhances nuclear one‑carbon metabolism in the nucleus accumbens, increasing SAM levels and promoting histone methylation at genes linked to synaptic plasticity and drug-seeking behavior. These results position chromatin as a metabolic sensor and suggest that targeting metabolic‑epigenetic coupling may offer new strategies for modulating maladaptive plasticity in addiction.
Shelley Warlow, PhD
Assistant Professor
Psychological and Brain Sciences
Dartmouth University
A Balancing Act: How Mesohabenular Co-transmission Shapes Reinforcement
Individual neurons projecting to lateral habenula (LHb) have the surprising capacity to co-release both GABA and glutamate, including a prominent input from ventral tegmental area (VTA). Yet it remains mysterious why neurons simultaneously release excitatory glutamate with inhibitory GABA onto the same post-synaptic cells. Here, we investigate the functional role of this GABA/glutamate co-transmission in LHb. We find that GABA/glutamate co-transmission inhibits LHb and supports positive reinforcement in mice. Yet, when LHb is in a hypoactive state, GABA/glutamate co-transmission switches to becoming excitatory and abolishing positive reinforcement. Our findings highlight GABA/glutamate co-transmission as a dynamic mechanism to normalize LHb activity, suppressing LHb when hyperactive while exciting LHb when hypoactive. This mechanism has broad implications for disorders of uncontrolled or imbalanced motivation such as addiction and bipolar disorder.
11:00am Data Blitz Presentations:
Increased somatic mutation rate in the OUD brain
Chen Fu
Senior Research Scientist
UMass Chan Medical School -Logan Lab
Alcohol seeking engages phenotypic BNST dynamics
Marie Doyle
Postdoctoral Associate
UMass Chan Medical School - Winder Lab
Prior exposure to voluntary wheel running promotes aversion-resistant ethanol intake in mice.
Danielle Adank
Graduate student
UMass Chan Medical School - Winder Lab
Brain Metabolite Changes Following MDMA-Assisted Therapy in Veterans with Comorbid PTSD-AUD
Lewis Nunez Severino
Graduate student
Brown University –Haass-Koffler Lab
A dopaminergic circuit pathway for operant alcohol preference in Drosophila melanogaster
John Hernandez
Assistant Professor (Research)
Brown University - Kaun Lab
Effects on neuroimmune signaling in rat brains after prenatal methadone exposure in male and female rats
Sandra Bartlett
Undergraduate Student
Simmons University - Gildawie Lab
Shifting the Curve: Nociceptin Decreases Cocaine Reward Sensitivity
Nick Bolden
Graduate student
UMass Chan Medical School – Melikian Lab
Investigating the neurocircuitry behind individual differences in stress reactivity and alcohol drinking in rats.
Sydney Bonauto
Graduate student
Tufts University – Weera Lab
Evaluating low-dose ketamine and (2R,6R)-Hydroxynorketamine as potential therapeutics for affective symptoms during opioid withdrawal
Michael Lehane
Graduate Student
University of Connecticut – Sartor Lab
Elucidating a Role for RTK Signaling in Fentanyl Reward
Matt Fanelli
Graduate student
UMass Chan Medical School – Puig Lab
The Role of Impaired Neurosteroid Synthesis in the BLA on Withdrawal-Induced Anxiety
Katrina Blandino
Graduate Student
Tufts University – Maguire Lab
Prolactin-releasing peptide (PrRP) in catecholaminergic neurons is involved in behavioral responses to stress
Caitlyn Edwards
Postdoctoral Associate/Fellow
UMass Chan Medical School - Winder Lab
Chasing the mechanisms linking Zhx2 dysfunction with changes in brain oxymorphone levels and oxycodone addiction model behaviors
Sophia Miracle
Graduate Student
Boston University – Bryant Lab
Targeting Keratinocytes to Make Opioids Safer.
Anita Khasnavis
Graduate student
UMass Chan Medical School – Puig Lab
Circulating growth factors as biomarkers for risk of adverse opioids outcomes
Angélique Buton
Investigator, Research Associate, Lab Manager
UMass Chan Medical School - Puig Lab
12:00pm Networking Lunch (check email for assigned group)
2:00pm inScopix
Miniaturized Two-Photon Brain Imaging During Naturalistic Behavior
Understanding the circuit-level basis of addiction and other complex brain disorders requires tools that capture cellular activity during naturalistic behavior. Inscopix enables this with an end-to-end platform supporting surgical procedures, data acquisition, and analysis for two-photon imaging in freely behaving animals. The nVista 2P, a plug-and-play miniature microscope system, allows researchers to image both deep and superficial brain regions over time, with high-resolution imaging that enables precise cell identification and longitudinal tracking. These capabilities are critical for uncovering how specific cell populations drive maladaptive behaviors and circuit reorganization over time.
2:05pm Invited Talks 2:
Jamie Maguire, PhD
Kenneth and JoAnn G Wellner Professor
Neuroscience
Tufts University
Alcohol modulation of BLA network states
Network states in the basolateral amygdala (BLA) have been shown to drive behavioral states. We examined the ability of both acute and chronic alcohol exposure to modulate BLA network states. We demonstrate that acute ethanol administration is capable of altering oscillations in the BLA, which may contribute to the anxiolytic effects of alcohol. Further, the extent to which alcohol modulates oscillations in the BLA correlates with the amount of future alcohol consumption. Finally, we demonstrate that chronic intermittent ethanol (CIE) exposure induces opposing, long-term shifts in BLA network states which may contribute to negative affective states associated with withdrawal.
Gilles Martin, PhD
Associate Professor
Neurobiology
UMass Chan Medical School
Suppression of binge alcohol drinking by an inhibitory neuronal ensemble in the mouse medial orbitofrontal cortex
In brain regions associated with alcohol, studies using fos as a marker of neuronal excitability established that only few neurons mediate its effects. These neurons are called neuronal ensembles. Whether these ensembles play a functional role and what determine their unique sensitivity to alcohol remain unclear. Using TRAP2 mice, a novel transgenic mouse model, we showed that binge alcohol drinking activates an ensemble in the medial orbitofrontal cortex (mOFC) that suppresses binge drinking behavior. Optogenetically silencing of this population, or its ablation, results in uncontrolled binge alcohol consumption. We also found that this neuronal ensemble is specific to alcohol and is not recruited by other rewarding substances. We further showed, using brain-wide analysis, that this neuronal ensemble projects widely, and that its projections specifically to the mediodorsal thalamus are responsible for regulating binge alcohol drinking. Together, we identified a brain circuit in the mOFC that serves to protect against binge drinking by halting alcohol intake.
Carolina Haass-Koffler, PhD
Associate Professor
Psychiatry and Human Behavior/ Behavioral and Social Sciences
Brown University
Targeting the stress system: development of Corticotropin Releasing Factor Binding Protein negative allosteric modulators
Stress response is believed to involve the corticotropin releasing factor (CRF) which interacts through its receptor and the CRF-binding protein (CRFBP). Recently, by utilizing novel a cell-based assay, we showed that the C-terminus of CRFBP(10 kD) fragment can potentiate CRF-intracellular Ca2+ release, demonstrating that CRFBP may possess excitatory roles in addition to the inhibitory role established by the N-terminus of CRFBP(27kD). This interaction is specific to the CRF receptor 2 (CRFR2). There are currently no small molecule ligands available that selectively interact with either CRFBP or CRFR2. We miniaturized the developed cell-based assay, where we expressed CRF-BP(10kD) on the plasma membrane fused as a chimera with CRF-R2a to develop a high throughput screening (HTS) assay. Hits were characterized in ex vivo electrophysiology assays that target: the CRF1+ neurons in the central nucleus of the amygdala (CeA) of CRF1:GFP mice that express GFP under the CRF1 promoter, and the CRF-induced potentiation of N-methyl-D-aspartic acid receptor (NMDAR)-mediated synaptic transmission in dopamine neurons in the ventral tegmental area (VTA). Also, hits were tested in vivo in a rodent model of alcohol use disorder. These results provide evidence of the first specific roles for CRFR2 and CRFBP in the modulation of neuronal activity and alcohol self-administration.
3:00pm Keynote address:
Dr. Danny Winder, Ph.D.
Worcester Foundation for Biomedical Research Chair I
Chair and Professor
Department of Neurobiology
UMass Chan Medical School
Diverse Minds, Shared Struggle: Neurobiological Insights into Alcohol Use Disorder through Heterogeneity and Co-morbidity
Alcohol Use Disorder (AUD) is a highly heterogeneous condition, necessitating personalized approaches that account for individual differences and co-occurring disorders to drive meaningful treatment progress. This presentation will highlight specific examples, including neural circuitries underlying sleep/wake behavior and depression, to illustrate the complexity of AUD. On a broader scale, we will explore the rich diversity, collaborative potential, and emerging opportunities within the New England addiction research community.
4:30pm Closing Statements (Dr. Danny Winder)
Location:
Smith Buonanno Hall, 95 Cushing St.
Rm 106
Brown University
Providence, RI
Driving directions and parking: https://www.brown.edu/about/visit/driving-parking
The closest Visitor Parking garage is the Power Street Garage (111 Power Street, aka Lot 68, Upper Floor is for visitors, $15/day, the garage has two gate arms which are left open: enter in the right lane and exit via the left lane). If it is full, try to find find street parking (some free and some paid, paid spots will need the Passport app).
Transit: Brown University is accessible from anywhere in Rhode Island via Rhode Island Public Transit Authority (RIPTA) bus. Bus and trolley routes terminate in Kennedy Plaza. Once there, these bus routes will take you through to Thayer Street (two blocks away from the conference building):
Schedules for all of these can be found online. The fare for both the bus and the trolley is $2. You may transfer at discounted rates; see the RIPTA website for detailed fare information.
The Amtrak / MBTA (Rail) Station is a ~15 minute walk / 5 minute drive from the conference building. The walk to Brown from the train station is up a fairly steep hill.
Sponsors: